Successful Use of Targeted HIF‐2α Inhibition in EPAS1‐Mutated Congenital Erythrocytosis
Year: 2025
Type: article
Study design: Case Report
Source: Pediatric Blood & Cancer
DOI: 10.1002/pbc.31966
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4413176170
